Accessibility Help | Sitemap | Contact Us | Customer Support CALL 800-668-5403
Careers | Investor Relations | News & Media | Events | About KCI
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support

Welcome to KCI, Leader in Advanced Wound Care Solutions

Features

News   Medical Professionals   Patient Stories
KCI, Leader in Advanced Wound Care Solutions KCI Announces New Management Structure
The Board of Directors of the parent company of Kinetic Concepts, Inc. and LifeCell Corporation today announced that Ronald A. Matricaria has joined the Board of Directors and will serve as its Chairman.
SkinIQ Skin IQ™ Microclimate Manager
The Skin IQ Microclimate Manager is a water resistant, vapor-permeable, bacterial/viral barrier cover system that uses KCI's unique Negative Airflow Technology.
Nigels Story - VAC Nigel’s Story
See how V.A.C.® Therapy helped a soldier win the fight against a terrible wound.
KCI, Leader in Advanced Wound Care Solutions KCI’s V.A.C.Via™ Therapy System Named a Leading Innovation by Podiatry Today
KCI’s V.A.C.Via™ Therapy System Named a Leading Innovation by Podiatry Today
Person holding VAC Via unit in hand Introducing the V.A.C.Via™ Negative Pressure Wound Therapy System
The V.A.C.Via™ System streamlines access to Negative Pressure Wound Therapy into a purchased single-use, portable, discreet device that provides 7 days of V.A.C.® Therapy.

V.A.C.® Therapy Reimbursement

Image of the ActiV.A.C. Therapy System

More information on reimbursement

About KCI

KCI is committed to advancing healing technology that positively impacts the lives of patients, their families, caregivers and providers alike.


Important Message for Patients

Legal Notice | Privacy Policy | Contact Us

© 1998 – 2012 KCI Licensing, Inc. All Rights Reserved. DSL# 09-03-193.CA

The information included in this Web site has been prepared for and is intended for viewing exclusively within Canada. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications and restriction in different countries.